1. Home
  2. CPSS vs GOSS Comparison

CPSS vs GOSS Comparison

Compare CPSS & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPSS
  • GOSS
  • Stock Information
  • Founded
  • CPSS 1991
  • GOSS 2015
  • Country
  • CPSS United States
  • GOSS United States
  • Employees
  • CPSS N/A
  • GOSS N/A
  • Industry
  • CPSS Finance: Consumer Services
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPSS Finance
  • GOSS Health Care
  • Exchange
  • CPSS Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • CPSS 225.2M
  • GOSS 212.8M
  • IPO Year
  • CPSS 1992
  • GOSS 2019
  • Fundamental
  • Price
  • CPSS $10.52
  • GOSS $1.40
  • Analyst Decision
  • CPSS
  • GOSS Strong Buy
  • Analyst Count
  • CPSS 0
  • GOSS 5
  • Target Price
  • CPSS N/A
  • GOSS $9.20
  • AVG Volume (30 Days)
  • CPSS 29.4K
  • GOSS 1.6M
  • Earning Date
  • CPSS 03-14-2025
  • GOSS 03-04-2025
  • Dividend Yield
  • CPSS N/A
  • GOSS N/A
  • EPS Growth
  • CPSS N/A
  • GOSS N/A
  • EPS
  • CPSS 0.87
  • GOSS N/A
  • Revenue
  • CPSS $184,246,000.00
  • GOSS $105,322,000.00
  • Revenue This Year
  • CPSS N/A
  • GOSS N/A
  • Revenue Next Year
  • CPSS $17.21
  • GOSS N/A
  • P/E Ratio
  • CPSS $12.11
  • GOSS N/A
  • Revenue Growth
  • CPSS N/A
  • GOSS N/A
  • 52 Week Low
  • CPSS $7.03
  • GOSS $0.50
  • 52 Week High
  • CPSS $12.73
  • GOSS $1.60
  • Technical
  • Relative Strength Index (RSI)
  • CPSS 38.44
  • GOSS 67.09
  • Support Level
  • CPSS $10.70
  • GOSS $1.37
  • Resistance Level
  • CPSS $11.67
  • GOSS $1.55
  • Average True Range (ATR)
  • CPSS 0.47
  • GOSS 0.13
  • MACD
  • CPSS -0.08
  • GOSS 0.03
  • Stochastic Oscillator
  • CPSS 0.00
  • GOSS 75.81

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S.-based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent, by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: